Citadel Advisors - ULTRAGENYX PHARMACEUTICAL IN ownership

Back to all holdings Add to watchlist

ULTRAGENYX PHARMACEUTICAL IN's ticker is and the CUSIP is 90400D958. A total of 2 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Citadel Advisors ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2016$421,000
-25.2%
8,600
-3.4%
0.00%
-100.0%
Q1 2016$563,000
+235.1%
8,900
+493.3%
0.00%–
Q4 2015$168,000
-75.8%
1,500
-79.2%
0.00%
-100.0%
Q3 2015$693,000
+513.3%
7,200
+554.5%
0.00%–
Q2 2015$113,000–1,100–0.00%–
 Download
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 16,200$649,6200.00%
JANE STREET GROUP, LLC 60,000$2,406,0000.00%
SIMPLEX TRADING, LLC 3,200$1280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders